BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Feng C, Zhang H, Chen J, Wang S, Xin Y, Qu Y, Zhang Q, Ji W, Yamashita F, Rui M, Xu X. Ratiometric co-encapsulation and co-delivery of doxorubicin and paclitaxel by tumor-targeted lipodisks for combination therapy of breast cancer. Int J Pharm 2019;560:191-204. [PMID: 30769131 DOI: 10.1016/j.ijpharm.2019.02.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Gupta U, Saren BN, Khaparkhuntikar K, Madan J, Singh PK. Applications of lipid-engineered nanoplatforms in the delivery of various cancer therapeutics to surmount breast cancer. J Control Release 2022;348:1089-115. [PMID: 35640765 DOI: 10.1016/j.jconrel.2022.05.034] [Reference Citation Analysis]
2 Diao W, Yang B, Sun S, Wang A, Kou R, Ge Q, Shi M, Lian B, Sun T, Wu J, Bai J, Qu M, Wang Y, Yu W, Gao Z. PNA-Modified Liposomes Improve the Delivery Efficacy of CAPIRI for the Synergistic Treatment of Colorectal Cancer. Front Pharmacol 2022;13:893151. [DOI: 10.3389/fphar.2022.893151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Xu X, Tian K, Lou X, Du Y. Potential of Ferritin-Based Platforms for Tumor Immunotherapy. Molecules 2022;27:2716. [DOI: 10.3390/molecules27092716] [Reference Citation Analysis]
4 Zhang J, Li C, Xue Q, Yin X, Li Y, He W, Chen X, Zhang J, Reis RL, Wang Y. An Efficient Carbon-Based Drug Delivery System for Cancer Therapy through the Nucleus Targeting and Mitochondria Mediated Apoptotic Pathway. Small Methods 2021;5:e2100539. [PMID: 34928029 DOI: 10.1002/smtd.202100539] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
5 Roque MC, da Silva CD, Lempek MR, Cassali GD, de Barros ALB, Melo MM, Oliveira MC. Preclinical toxicological study of long-circulating and fusogenic liposomes co-encapsulating paclitaxel and doxorubicin in synergic ratio. Biomed Pharmacother 2021;144:112307. [PMID: 34653762 DOI: 10.1016/j.biopha.2021.112307] [Reference Citation Analysis]
6 Levy ES, Yu J, Estevez A, Mao J, Liu L, Torres E, Leung D, Yen CW. A Systematic Approach for Liposome and Lipodisk Preclinical Formulation Development by Microfluidic Technology. AAPS J 2021;23:111. [PMID: 34651233 DOI: 10.1208/s12248-021-00651-4] [Reference Citation Analysis]
7 Zhang D, Jiang L, Liu C. A convergent synthetic platform for polymeric nanoparticle for the treatment of combination colorectal cancer therapy. J Biomater Sci Polym Ed 2021;:1-14. [PMID: 34121628 DOI: 10.1080/09205063.2021.1941556] [Reference Citation Analysis]
8 Li Y, Hou H, Zhang P, Zhang Z. Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy. Drug Deliv 2020;27:1044-53. [PMID: 32633576 DOI: 10.1080/10717544.2020.1785049] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
9 Basu SM, Yadava SK, Singh R, Giri J. Lipid nanocapsules co-encapsulating paclitaxel and salinomycin for eradicating breast cancer and cancer stem cells. Colloids Surf B Biointerfaces 2021;204:111775. [PMID: 33940518 DOI: 10.1016/j.colsurfb.2021.111775] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Voci S, Gagliardi A, Molinaro R, Fresta M, Cosco D. Recent Advances of Taxol-Loaded Biocompatible Nanocarriers Embedded in Natural Polymer-Based Hydrogels. Gels 2021;7:33. [PMID: 33804970 DOI: 10.3390/gels7020033] [Reference Citation Analysis]
11 Wang Y, Xiao F, Shao T, Hu K, Lian G, Feng J, Chen H, Jin G. A multiple acetal chalcone-BODIPY-based fluorescence: synthesis, physical property, and biological studies. Anal Bioanal Chem 2021;413:2529-41. [PMID: 33712915 DOI: 10.1007/s00216-021-03208-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhang Z, Yue YX, Xu L, Wang Y, Geng WC, Li JJ, Kong XL, Zhao X, Zheng Y, Zhao Y, Shi L, Guo DS, Liu Y. Macrocyclic-Amphiphile-Based Self-Assembled Nanoparticles for Ratiometric Delivery of Therapeutic Combinations to Tumors. Adv Mater 2021;33:e2007719. [PMID: 33598992 DOI: 10.1002/adma.202007719] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 20.0] [Reference Citation Analysis]
13 Drescher S, van Hoogevest P. The Phospholipid Research Center: Current Research in Phospholipids and Their Use in Drug Delivery. Pharmaceutics 2020;12:E1235. [PMID: 33353254 DOI: 10.3390/pharmaceutics12121235] [Cited by in Crossref: 4] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
14 Grad P, Gedda L, Edwards K. Effect of gangliosides on structure and integrity of polyethylene glycol (PEG)-stabilized liposomes. Journal of Colloid and Interface Science 2020;578:281-9. [DOI: 10.1016/j.jcis.2020.05.120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
15 Yu J, Wang Y, Zhou S, Li J, Wang J, Chi D, Wang X, Lin G, He Z, Wang Y. Remote loading paclitaxel-doxorubicin prodrug into liposomes for cancer combination therapy. Acta Pharm Sin B 2020;10:1730-40. [PMID: 33088692 DOI: 10.1016/j.apsb.2020.04.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
16 Khan DH, Bashir S, Khan MI, Figueiredo P, Santos HA, Peltonen L. Formulation optimization and in vitro characterization of rifampicin and ceftriaxone dual drug loaded niosomes with high energy probe sonication technique. Journal of Drug Delivery Science and Technology 2020;58:101763. [DOI: 10.1016/j.jddst.2020.101763] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Lundsten S, Hernández VA, Gedda L, Sarén T, Brown CJ, Lane DP, Edwards K, Nestor M. Tumor-Targeted Delivery of the p53-Activating Peptide VIP116 with PEG-Stabilized Lipodisks. Nanomaterials (Basel) 2020;10:E783. [PMID: 32325827 DOI: 10.3390/nano10040783] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
18 Huang HL, Lin WJ. Dual Peptide-Modified Nanoparticles Improve Combination Chemotherapy of Etoposide and siPIK3CA Against Drug-Resistant Small Cell Lung Carcinoma. Pharmaceutics 2020;12:E254. [PMID: 32178266 DOI: 10.3390/pharmaceutics12030254] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
19 Xie M, Yang N, Cheng J, Yang M, Deng T, Li Y, Feng C. Layered MoS2 nanosheets modified by biomimetic phospholipids: Enhanced stability and its synergistic treatment of cancer with chemo-photothermal therapy. Colloids and Surfaces B: Biointerfaces 2020;187:110631. [DOI: 10.1016/j.colsurfb.2019.110631] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
20 Zha L, Wang B, Qian J, Fletcher B, Zhang C, Dong Q, Chen W, Hong L. Preparation, characterization and preliminary pharmacokinetic study of pH-sensitive Hydroxyapatite/Zein nano-drug delivery system for doxorubicin hydrochloride. J Pharm Pharmacol 2020;72:496-506. [PMID: 31975457 DOI: 10.1111/jphp.13223] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
21 Wu X, Chen S, Lu C. Amyloid precursor protein promotes the migration and invasion of breast cancer cells by regulating the MAPK signaling pathway. Int J Mol Med 2020;45:162-74. [PMID: 31746365 DOI: 10.3892/ijmm.2019.4404] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
22 Wu D, Chen Y, Wen S, Wen Y, Wang R, Zhang Q, Qin G, Yi H, Wu M, Lu L, Tao X, Deng X. Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells. Nanoscale Res Lett 2019;14:314. [PMID: 31520223 DOI: 10.1186/s11671-019-3146-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]